Cancer patients denied best antibiotics due to false allergy fears
NCT ID NCT07133074
Summary
This study aims to see if safely testing and removing incorrect penicillin allergy labels helps hospitalized blood cancer patients. Many patients report this allergy, but studies show 90% can actually tolerate these preferred antibiotics. Researchers will have pharmacists assess patients' allergy history and conduct tests to 'de-label' those who are not truly allergic, hoping this leads to better antibiotic use, shorter hospital stays, and fewer dangerous infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.